Skip to main content

Table 5 Regression analysis for predictive factors for tolerance

From: Allograft tolerance after adult living donor liver transplantation: a case-control study

 

Unadjusted OR (95% CI)

P-value

Adjusted OR (95% CI)

P-value

Age at LT

1.04 (1.01–1.08)

0.01*

1.034 (0.99–1.08)

0.082

Male

1.283 (0.54–3.06)

0.575

1.7 (0.61–4.76)

0.308

Pre-LT MELD

0.95 (0.91–0.997)

0.037*

0.95 (0.9–0.99)

0.033*

Related donation

1.53 (0.89–2.61)

0.118

1.23 (0.68–2.24)

0.492

ABO-Rh compatibility

0.87 (0.53–1.44)

0.597

0.81 (0.46–1.46)

0.459

Diagnosis HCV/HCC

0.94 (0.57–1.55)

0.804

0.62 (0.35–1.09)

0.096

Diagnosis HCV/Others

0.39 (0.15–1.4)

0.06

0.23 (0.08–0.72)

0.011*

ACR

0.34 (0.21–0.55)

< 0.001*

0.36 (0.21–0.62)

0.001*

Post-LT viral hepatitis

0.44 (0.27–0.73)

0.001*

0.44 (0.25–0.78)

0.005*

Biliary complications

0.31 (0.19–0.5)

< 0.001*

0.28 (0.16–0.48)

0.001*

  1. Abbreviations OR: LT: Liver Transplantation, MELD: Model for End-stage Liver Disease, HCV: Hepatitis C Virus, HCC: Hepatocellular Carcinoma, ACR: Acute Cellular Rejection. Others: refer to Hepatitis B virus cirrhosis, Welson’s disease, Cryptogenic cirrhosis, and Budd-Chiari Syndrome
  2. (*) indicates statistical significance (P < 0.05)